When a surgical flap or a replanted finger turns dusky and swollen, arterial blood is arriving but venous blood cannot leave. Medicinal leeches remain one of the few tools that can buy that tissue time.
Venous congestion is a race against the clock. Inflow continues to deliver blood into tissue whose outflow has failed, raising pressure until perfusion stops and the tissue dies. Re-establishing venous drainage surgically is not always immediately possible — and that is the window in which leech therapy earns its place.
Why a leech, and not a needle
A medicinal leech does two things at once. It actively removes a volume of congested blood, and — more importantly — its saliva introduces a complex of anticoagulant and vasoactive compounds, including hirudin, that keep the bite site bleeding gently after the animal detaches. That prolonged ooze is the therapeutic effect: it decompresses the tissue for hours, far beyond the few minutes the leech is attached.
Where it is used
- Skin and muscle flaps with venous compromise
- Replanted digits and other small-part replantation
- Free-tissue transfer showing early venous congestion
- Selected ear, lip and nasal reconstructions
What a supply partner must guarantee
Clinical use depends on the animal being medical-grade: bred under controlled conditions, fasted so it attaches and draws reliably, graded to the procedure, and delivered alive and active through a managed cold-chain. Anything less is a clinical risk, not a saving.